Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Retained Earnings (2016 - 2025)

Fortress Biotech (FBIO) has 13 years of Retained Earnings data on record, last reported at -$730.1 million in Q3 2025.

  • For Q3 2025, Retained Earnings rose 0.54% year-over-year to -$730.1 million; the TTM value through Sep 2025 reached -$730.1 million, up 0.54%, while the annual FY2024 figure was -$740.9 million, 6.62% down from the prior year.
  • Retained Earnings reached -$730.1 million in Q3 2025 per FBIO's latest filing, up from -$736.0 million in the prior quarter.
  • Across five years, Retained Earnings topped out at -$491.6 million in Q1 2021 and bottomed at -$751.5 million in Q1 2025.
  • Average Retained Earnings over 5 years is -$646.3 million, with a median of -$680.5 million recorded in 2023.
  • Peak YoY movement for Retained Earnings: dropped 18.07% in 2022, then grew 0.54% in 2025.
  • A 5-year view of Retained Earnings shows it stood at -$547.5 million in 2021, then dropped by 15.85% to -$634.2 million in 2022, then decreased by 9.56% to -$694.9 million in 2023, then fell by 6.62% to -$740.9 million in 2024, then grew by 1.45% to -$730.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Retained Earnings were -$730.1 million in Q3 2025, -$736.0 million in Q2 2025, and -$751.5 million in Q1 2025.